ANHTHU BUI: Open Payments
NPI 1164994570 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 65 payments from 11 companies in 2025. Trend: 2023 $1,525 · 2024 $1,641 · 2025 $1,666
Food & beverage: $1,569Education: $97
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $357 |
| Novo Nordisk Inc | 7 | $278 |
| Amgen Inc. | 9 | $257 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $230 |
| Lilly USA, LLC | 9 | $172 |
| Gilead Sciences, Inc. | 6 | $124 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Sumitomo Pharma America, Inc. | 3 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Radius Health, Inc. | 2 | $39 |
Products named: BREZTRI, Kerendia, Ozempic, REPATHA, JARDIANCE, TRELEGY ELLIPTA, OTEZLA, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
